BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 81 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,944,000 | -41.9% | 70,801 | -52.4% | 0.82% | -38.1% |
| Q3 2016 | $6,787,000 | -27.4% | 148,599 | -36.5% | 1.32% | -21.0% |
| Q2 2016 | $9,352,000 | +19.1% | 234,159 | +3.8% | 1.67% | +28.2% |
| Q1 2016 | $7,853,000 | -17.2% | 225,518 | +2.2% | 1.30% | -21.4% |
| Q4 2015 | $9,480,000 | +33.7% | 220,618 | +35.5% | 1.66% | +27.5% |
| Q3 2015 | $7,089,000 | +17.2% | 162,806 | +38.9% | 1.30% | +18.6% |
| Q2 2015 | $6,048,000 | – | 117,206 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |